Novo Nordisk's chairman Helge Lund and six independent directors are stepping down after failing to reach agreement with majority shareholder over pace of board transformation as company faces market challenges.
Blackstone and TPG are acquiring women's health leader Hologic for up to $18.3 billion in one of 2025's largest healthcare buyouts, with shareholders receiving $76-$79 per share.
Biotech firm Galapagos winds down cell therapy business affecting 365 jobs across 5 countries after unsuccessful sale attempts. Stock drops 15% on announcement.
Elevance Health surpasses Wall Street Q3 profit estimates with $6.03 adjusted EPS, managing medical costs better than expected despite ongoing healthcare industry challenges.
DocGo acquires virtual care platform SteadyMD for $25M, sending shares up 40%. The deal expands DocGo's telehealth capabilities across all 50 states as revenue declines.
Perspective Therapeutics shares fell 29% to $3.19 after presenting Phase 1/2a trial data for VMT-alpha-NET. Analysts split on outlook despite favorable safety profile and $174M cash position through late 2026.
